Skip to main content
Livermore
Livermore
ZHEN

Elevated Capital Advisors, LLC

SEC CIK
0001802387
Latest filing
Aug 3, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Elevated Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
3,945
Value
$992.7K
% of portfolio
0.3%
Quarters held
19
Since Q1 2021
Holdings of ABBV by Elevated Capital Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,945$992.7K0.3%−2,390−37.7%ReducedHolders
Q1 20266,335$1.38M0.3%−3,139−33.1%ReducedHolders
Q4 20259,474$2.16M0.5%−3,583−27.4%ReducedHolders
Q3 202513,057$3.02M0.8%+650+5.2%AddedHolders
Q2 202512,407$2.60M0.7%00.0%UnchangedHolders
Q1 202512,407$2.60M0.7%−682−5.2%ReducedHolders
Q4 202413,089$2.33M0.6%+1,377+11.8%AddedHolders
Q3 202411,712$2.31M0.6%+1,995+20.5%AddedHolders
Q2 20249,717$1.67M0.5%−8,988−48.1%ReducedHolders
Q1 202418,705$3.41M1.0%+324+1.8%AddedHolders
Q4 202318,381$2.85M0.9%+266+1.5%AddedHolders
Q3 202318,115$2.70M0.9%+1,131+6.7%AddedHolders
Q2 202316,984$2.29M0.8%+755+4.7%AddedHolders
Q1 202316,229$2.59M0.9%+36+0.2%AddedHolders
Q4 202216,193$2.62M1.0%+3,019+22.9%AddedHolders
Q3 202213,174$1.77M0.7%–No prior filingHolders
Q2 2022––––Not filedHolders
Q1 202213,109$2.13M0.7%–No prior filingHolders
Q4 2021––––Not filedHolders
Q3 202112,588$1.36M0.5%–No prior filingHolders
Q2 2021––––Not filedHolders
Q1 202111,670$1.27M0.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.